The purpose of this combined retrospective and prospective clinical study is to examine safety and efficacy of the ROI-C® anterior cervical interbody fusion device with VerteBRIDGE® plating to treat single level degenerative disc disease between C2 and T1 in the short term, with a focus on fusion rates.